Cipla Limited

Industry

  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Nutraceuticals
    • Generic Drugs
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Contract Research Organization-CRO

Other Names/Subsidiaries

  • Actor Pharma
  • Cipla Gulf FZ LLC
  • Cipla Technologies LLC
  • InvaGen Pharmaceuticals Inc.
  • Mirren Pty, Ltd.
  • Breathe Free Lanka
  • Cipla BioTec South Africa
  • Cipla Medpro South Africa
  • Exelan Pharmaceuticals
  • InvaGen Pharmaceuticals
  • mabpharm
  • Medica Pharmaceutical Industries
  • Meditab Holdings
  • Med Man Care
  • Medpro Pharmaceutica
  • Okasa Pharma
  • Quality Chemicals
  • Xeragen Laboratories
See more in Biomedtracker

Latest on Cipla Limited

Pink Sheet

Lerodalcibep And First Generic Palbociclib Among 10 New EMA Filings

 
• By Neena Brizmohun

The European Medicines Agency has begun reviewing a new batch of products for potential pan-EU marketing approval, including LIB Therapeutics’ lerodalcibep for treating primary hypercholesterolemia or

Generics Bulletin

Cipla Leadership’s Early Take On Trump’s Pricing EO And Pipeline Progress

 
• By Anju Ghangurde

Frontline Indian company Cipla said that an early assessment of US President Donald Trump’s executive order (EO) aimed at reducing prescription drug prices in line with those paid by similar nations

Scrip

Cipla Leadership’s Early Take On Trump’s Pricing EO And Pipeline Progress

 
• By Anju Ghangurde

Frontline Indian company Cipla said that an early assessment of US President Donald Trump’s executive order (EO) aimed at reducing prescription drug prices in line with those paid by similar nations s

Generics Bulletin

Cipla Welcomes Abraxane ANDA Approval After Tackling Goa Compliance Issues

 
• By Dean Rudge

Following years of development and setbacks, Cipla has won US Food and Drug Administration approval for a generic version of Bristol Myers Squibb’s hard-to-manufacture Abraxane (protein-bound paclitax